Auditory neurophysiology reveals central nervous system dysfunction in HIV-infected individuals

被引:13
作者
White-Schwoch, Travis [1 ]
Magohe, Albert K. [2 ]
Fellows, Abigail M. [3 ]
Rieke, Catherine C. [3 ]
Vilarello, Brandon [1 ]
Nicol, Trent [1 ]
Massawe, Enica R. [2 ]
Moshi, Ndeserua [2 ]
Kraus, Nina [1 ]
Buckey, Jay C. [3 ]
机构
[1] Northwestern Univ, Auditory Neurosci Lab, Dept Commun Sci, Evanston, IL USA
[2] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania
[3] Geisel Sch Med Dartmouth, Space Med Innovat Lab, Hanover, NH 03755 USA
关键词
HIV; Frequency-following response; Auditory processing; Electrophysiology; Auditory neurophysiology; ANTIRETROVIRAL THERAPY; COGNITIVE IMPAIRMENT; NOISE PERCEPTION; HEARING-LOSS; SPEECH; BRAIN; DEFICITS;
D O I
10.1016/j.clinph.2020.04.165
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To test the hypothesis that human immunodeficiency virus (HIV) affects auditory-neurophysiological functions. Methods: A convenience sample of 68 HIV+ and 59 HIV- normal-hearing adults was selected from a study set in Dar es Salaam, Tanzania. The speech-evoked frequency-following response (FFR), an objective measure of auditory function, was collected. Outcome measures were FFRs to the fundamental frequency (F0) and to harmonics corresponding to the first formant (F1), two behaviorally relevant cues for understanding speech. Results: The HIV+ group had weaker responses to the F1 than the HIV- group; this effect generalized across multiple stimuli (d = 0.59). Responses to the F0 were similar between groups. Conclusions: Auditory-neurophysiological responses differ between HIV+ and HIV- adults despite normal hearing thresholds. Significance: The FFR may reflect HIV-associated central nervous system dysfunction that manifests as disrupted auditory processing of speech harmonics corresponding to the first formant. (C) 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1827 / 1832
页数:6
相关论文
共 50 条
  • [41] Immunotherapeutic restoration in HIV-infected individuals
    Kim, June Myung
    Han, Sang Hoon
    IMMUNOTHERAPY, 2011, 3 (02) : 247 - 267
  • [42] The use of caspofungin in HIV-infected individuals
    Waters, Laura
    Nelson, Mark
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 899 - 908
  • [43] Metagenomic next-generation sequencing for identification of central nervous system pathogens in HIV-infected patients
    Zhu, Yunqi
    Zhao, Wenxuan
    Yang, Xihong
    Zhang, Yuanyuan
    Lin, Xiaoling
    Weng, Xing
    Wang, Yali
    Cheng, Cong
    Chi, Yun
    Wei, Hongxia
    Peng, Zhihang
    Hu, Zhiliang
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [44] Vocal emotion processing deficits in HIV-infected individuals
    Gonzalez-Baeza, A.
    Arribas, J. R.
    Perez-Valero, I.
    Monge, S.
    Bayon, C.
    Martin, P.
    Rubio, S.
    Carvajal, F.
    JOURNAL OF NEUROVIROLOGY, 2017, 23 (02) : 304 - 312
  • [45] Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals
    Thomas A. Premeaux
    Michelle L. D’Antoni
    Mohamed Abdel-Mohsen
    Satish K. Pillai
    Kalpana J. Kallianpur
    Beau K. Nakamoto
    Melissa Agsalda-Garcia
    Bruce Shiramizu
    Cecilia M. Shikuma
    Magnus Gisslén
    Richard W. Price
    Victor Valcour
    Lishomwa C. Ndhlovu
    Journal of NeuroVirology, 2019, 25 : 150 - 161
  • [46] Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals
    Premeaux, Thomas A.
    D'Antoni, Michelle L.
    Abdel-Mohsen, Mohamed
    Pillai, Satish K.
    Kallianpur, Kalpana J.
    Nakamoto, Beau K.
    Agsalda-Garcia, Melissa
    Shiramizu, Bruce
    Shikuma, Cecilia M.
    Gisslen, Magnus
    Price, Richard W.
    Valcour, Victor
    Ndhlovu, Lishomwa C.
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (02) : 150 - 161
  • [47] The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals
    Baker, Laurie M.
    Paul, Robert H.
    Heaps-Woodruff, Jodi M.
    Chang, Jee Yoon
    Ortega, Mario
    Margolin, Zachary
    Usher, Christina
    Basco, Brian
    Cooley, Sarah
    Ances, Beau M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 (03) : 487 - 492
  • [48] Aortic stiffness aging is influenced by past profound immunodeficiency in HIV-infected individuals: results from the EVAS-HIV (EValuation of Aortic Stiffness in HIV-infected individuals)
    Maia-Leite, Luisa H.
    Catez, Emmanuel
    Boyd, Anders
    Haddour, Nabila
    Curjol, Angelique
    Lang, Sylvie
    Nuernberg, Mabel
    Duvivier, Claudine
    Desvarieux, Moise
    Kirstetter, Miriam
    Girard, Pierre-Marie
    Cohen, Ariel
    Boccara, Franck
    JOURNAL OF HYPERTENSION, 2016, 34 (07) : 1338 - 1346
  • [49] Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007
    Cordova, Ezequiel
    Boschi, Analia
    Ambrosioni, Juan
    Cudos, Carolina
    Corti, Marcelo
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (06) : 587 - 592
  • [50] Differential gene expression in HIV-infected individuals following ART
    Massanella, Marta
    Singhania, Akul
    Beliakova-Bethell, Nadejda
    Pier, Rose
    Lada, Steven M.
    White, Cory H.
    Perez-Santiago, Josue
    Blanco, Julia
    Richman, Douglas D.
    Little, Susan J.
    Woelk, Christopher H.
    ANTIVIRAL RESEARCH, 2013, 100 (02) : 420 - 428